Skip to main content
EJNMMI Research
Fig. 6 | EJNMMI Research

Fig. 6

From: Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers

Fig. 6

Regional decay-corrected TACs of 16 source organs (a-d) after intravenous injection of [11C]CB184 into the same subject as shown in Fig. 5. TACs were expressed as percent of injected dose (%ID). Each panels showed the TACs of source organs with high (a), moderate (b), low (c) and very low (d) radioactivity. Activities in bone marrow were estimated from thoracic and lumbar vertebrae. The initial time point for the lungs (25%ID at 3.3 min) was deleted because this high value unnecessarily extended the y-axis

Back to article page